Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Mol Genet ; 27(13): 2367-2382, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29701772

ABSTRACT

Core myopathies are a group of childhood muscle disorders caused by mutations of the ryanodine receptor (RyR1), the Ca2+ release channel of the sarcoplasmic reticulum. These mutations have previously been associated with elevated inositol trisphosphate receptor (IP3R) levels in skeletal muscle myotubes derived from patients. However, the functional relevance and the relationship of IP3R mediated Ca2+ signalling with the pathophysiology of the disease is unclear. It has also been suggested that mitochondrial dysfunction underlies the development of central and diffuse multi-mini-cores, devoid of mitochondrial activity, which is a key pathological consequence of RyR1 mutations. Here we used muscle biopsies of central core and multi-minicore disease patients with RyR1 mutations, as well as cellular and in vivo mouse models of the disease to characterize global cellular and mitochondrial Ca2+ signalling, mitochondrial function and gene expression associated with the disease. We show that RyR1 mutations that lead to the depletion of the channel are associated with increased IP3-mediated nuclear and mitochondrial Ca2+ signals and increased mitochondrial activity. Moreover, western blot and microarray analysis indicated enhanced mitochondrial biogenesis at the transcriptional and protein levels and was reflected in increased mitochondrial DNA content. The phenotype was recapitulated by RYR1 silencing in mouse cellular myotube models. Altogether, these data indicate that remodelling of skeletal muscle Ca2+ signalling following loss of functional RyR1 mediates bioenergetic adaptation.


Subject(s)
Inositol 1,4,5-Trisphosphate Receptors/genetics , Mitochondria/genetics , Muscular Diseases/genetics , Ryanodine Receptor Calcium Release Channel/genetics , Animals , Calcium Signaling/genetics , Gene Expression Regulation , Humans , Inositol/metabolism , Mice , Mitochondria/metabolism , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/pathology , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscular Diseases/metabolism , Muscular Diseases/pathology , Mutation
2.
Biochim Biophys Acta Mol Cell Res ; 1864(6): 1009-1017, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28132899

ABSTRACT

Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca2+ uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitochondrial Ca2+ concentration ([Ca2+]m). We now explore the functional consequences of MICU1 mutations in patient derived fibroblasts in order to clarify the underlying pathophysiology of this disorder. We propose that deregulation of mitochondrial Ca2+ uptake through loss of MICU1 raises resting [Ca2+]m, initiating a futile Ca2+ cycle, whereby continuous mitochondrial Ca2+ influx is balanced by Ca2+ efflux through the sodium calcium exchanger (NLCXm). Thus, inhibition of NCLXm by CGP-37157 caused rapid mitochondrial Ca2+ accumulation in patient but not control cells. We suggest that increased NCLX activity will increase sodium/proton exchange, potentially undermining oxidative phosphorylation, although this is balanced by dephosphorylation and activation of pyruvate dehydrogenase (PDH) in response to the increased [Ca2+]m. Consistent with this model, while ATP content in patient derived or control fibroblasts was not different, ATP increased significantly in response to CGP-37157 in the patient but not the control cells. In addition, EMRE expression levels were altered in MICU1 patient cells compared to the controls. The MICU1 mutations were associated with mitochondrial fragmentation which we show is related to altered DRP1 phosphorylation. Thus, MICU1 serves as a signal-noise discriminator in mitochondrial calcium signalling, limiting the energetic costs of mitochondrial Ca2+ signalling which may undermine oxidative phosphorylation, especially in tissues with highly dynamic energetic demands. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech.


Subject(s)
Calcium Signaling , Calcium-Binding Proteins/genetics , Cation Transport Proteins/genetics , Energy Metabolism , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/genetics , Mutation , Cells, Cultured , Humans
3.
Ann N Y Acad Sci ; 1350: 107-16, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26375864

ABSTRACT

Calcium signaling is pivotal to a host of physiological pathways. A rise in calcium concentration almost invariably signals an increased cellular energy demand. Consistent with this, calcium signals mediate a number of pathways that together serve to balance energy supply and demand. In pathological states, calcium signals can precipitate mitochondrial injury and cell death, especially when coupled to energy depletion and oxidative or nitrosative stress. This review explores the mechanisms that couple cell signaling pathways to metabolic regulation or to cell death. The significance of these pathways is exemplified by pathological case studies, such as those showing loss of mitochondrial calcium uptake 1 in patients and ischemia/reperfusion injury.


Subject(s)
Calcium Signaling , Cell Death , Energy Metabolism , Mitochondria/metabolism , Models, Biological , Animals , Apoptosis , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Humans , Mitochondria/pathology , Mitochondrial Membrane Transport Proteins/genetics , Mitochondrial Membrane Transport Proteins/metabolism , Mitochondrial Membranes/chemistry , Mitochondrial Membranes/metabolism , Mitochondrial Membranes/pathology , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Mutation , Necrosis , Permeability , Phosphate Transport Proteins/genetics , Phosphate Transport Proteins/metabolism , Porosity
4.
Nat Genet ; 46(2): 188-93, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24336167

ABSTRACT

Mitochondrial Ca(2+) uptake has key roles in cell life and death. Physiological Ca(2+) signaling regulates aerobic metabolism, whereas pathological Ca(2+) overload triggers cell death. Mitochondrial Ca(2+) uptake is mediated by the Ca(2+) uniporter complex in the inner mitochondrial membrane, which comprises MCU, a Ca(2+)-selective ion channel, and its regulator, MICU1. Here we report mutations of MICU1 in individuals with a disease phenotype characterized by proximal myopathy, learning difficulties and a progressive extrapyramidal movement disorder. In fibroblasts from subjects with MICU1 mutations, agonist-induced mitochondrial Ca(2+) uptake at low cytosolic Ca(2+) concentrations was increased, and cytosolic Ca(2+) signals were reduced. Although resting mitochondrial membrane potential was unchanged in MICU1-deficient cells, the mitochondrial network was severely fragmented. Whereas the pathophysiology of muscular dystrophy and the core myopathies involves abnormal mitochondrial Ca(2+) handling, the phenotype associated with MICU1 deficiency is caused by a primary defect in mitochondrial Ca(2+) signaling, demonstrating the crucial role of mitochondrial Ca(2+) uptake in humans.


Subject(s)
Calcium Signaling/genetics , Calcium-Binding Proteins/genetics , Cation Transport Proteins/genetics , Learning Disabilities/genetics , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/genetics , Movement Disorders/genetics , Muscular Diseases/genetics , Phenotype , Analysis of Variance , Base Sequence , Calcium Channels/metabolism , Calcium Signaling/physiology , Calcium-Binding Proteins/metabolism , Cation Transport Proteins/metabolism , DNA, Complementary/genetics , Exome/genetics , Extrapyramidal Tracts/pathology , Fluorescent Antibody Technique , Histological Techniques , Humans , Immunohistochemistry , Membrane Potential, Mitochondrial/genetics , Mitochondrial Membrane Transport Proteins/metabolism , Molecular Sequence Data , Pedigree , Polymorphism, Single Nucleotide/genetics , Quadriceps Muscle/pathology , Real-Time Polymerase Chain Reaction , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...